检查坚持"监管+普法"并重，现场解读《药品管理法》《医疗器械监督管理条例》等法规，发放相关宣 传资料60余份，增强经营者守法诚信意识并规范经营。下一步，新疆沙湾市市监局将持续加大巡查力 度，畅通投诉举报渠道，对违法违规行为保持"零容忍"高压态势，全力护航群众冬季用药用械安全。 （通讯员 韩剑报道）冬季是药品、医疗器械消费旺季，流感、呼吸道等疾病进入高发期，群众购药购 械需求激增，是药械质量安全风险防控关键期。新疆沙湾市市场监督管理局以专项检查为有力抓手，在 全市开展药品、医疗器械质量安全专项检查，筑牢民生安全防线。此次检查聚焦城乡结合部等风险易发 区域，覆盖零售药店、医疗机构、医疗器械专营企业等经营使用单位，实现高风险领域监管无死角。药 品监管领域，执法人员紧扣群众冬季用药需求，重点核查购进渠道、储存条件等关键环节，紧盯感冒退 热、慢性病及儿童用药等重点品种，严查处方药违规销售、哄抬物价等违法行为。医疗器械领域，以无 菌、植入性、冷链器械为监管重点，深入核查证照是否齐全，产品注册备案、购进验收及储存管理等情 况。 ...

Core Viewpoint - The Xinjiang Shawan City Market Supervision Administration is implementing a "Party Building Guidance + Law Enforcement Supervision" integration model to enhance the safety of drug and medical device usage during the winter respiratory disease peak season [1] Group 1: Party Building and Regulatory Integration - The administration has appointed party member law enforcement officers as Party Building Guides to work closely with local drug and medical device businesses, promoting the integration of party building and regulatory oversight [1] - These guides serve dual roles as enforcement inspectors and party building counselors, helping businesses improve their party organization and management systems [1] Group 2: Focus on Drug Safety - The initiative emphasizes strict checks on key drug categories such as cold medications and chronic disease treatments, ensuring compliance with regulations regarding procurement, qualifications, storage conditions, and prescription drug sales [1] - The administration plans to increase the frequency of market inspections and intensify efforts to combat illegal activities, aiming to enhance the standardization of drug and medical device businesses [1]

Core Viewpoint - The Shaanxi Provincial Drug Administration has released a plan for drug supervision and management for 2025, emphasizing the need to strengthen regulation in key varieties, links, enterprises, and regions to ensure drug quality and safety [1][2] Group 1: Regulatory Actions - Shaanxi will implement the "Qingyuan" action, focusing on drug wholesale and retail enterprises, as well as online sales, to combat illegal drug purchasing and selling channels [1] - The province aims to enhance the traceability system for drug operations, ensuring comprehensive coverage of five categories of drugs through QR code tracking [1] Group 2: Quality Supervision - Increased regulatory efforts will be directed towards vaccines, blood products, and commonly used high-value drugs, with special inspections for traditional Chinese medicine (TCM) products [1] - There will be a focus on prescription drugs and chronic disease medications, particularly in monitoring procurement channels, storage management, and information traceability [1] Group 3: Targeted Inspections - The Shaanxi Provincial Drug Administration will strengthen oversight of illegal sales of TCM formula granules and prescription drugs without proper prescriptions, as well as the absence of licensed pharmacists [2] - Special attention will be given to rural areas and small pharmacies, ensuring they have established quality management systems for drug procurement, acceptance, and storage [2] - Investigations will target issues such as substandard storage conditions and the illegal sale of TCM products, including the sale of inferior or counterfeit goods [2]